1. Home
  2. AIMD vs JAGX Comparison

AIMD vs JAGX Comparison

Compare AIMD & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • JAGX
  • Stock Information
  • Founded
  • AIMD 1984
  • JAGX 2013
  • Country
  • AIMD United States
  • JAGX United States
  • Employees
  • AIMD N/A
  • JAGX N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIMD Health Care
  • JAGX Health Care
  • Exchange
  • AIMD Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • AIMD 8.2M
  • JAGX 7.4M
  • IPO Year
  • AIMD N/A
  • JAGX N/A
  • Fundamental
  • Price
  • AIMD $0.54
  • JAGX $5.50
  • Analyst Decision
  • AIMD
  • JAGX
  • Analyst Count
  • AIMD 0
  • JAGX 0
  • Target Price
  • AIMD N/A
  • JAGX N/A
  • AVG Volume (30 Days)
  • AIMD 168.9K
  • JAGX 245.8K
  • Earning Date
  • AIMD 05-12-2025
  • JAGX 05-15-2025
  • Dividend Yield
  • AIMD N/A
  • JAGX N/A
  • EPS Growth
  • AIMD N/A
  • JAGX N/A
  • EPS
  • AIMD N/A
  • JAGX N/A
  • Revenue
  • AIMD $20,729.00
  • JAGX $11,689,000.00
  • Revenue This Year
  • AIMD N/A
  • JAGX $22.41
  • Revenue Next Year
  • AIMD N/A
  • JAGX $30.00
  • P/E Ratio
  • AIMD N/A
  • JAGX N/A
  • Revenue Growth
  • AIMD N/A
  • JAGX 19.75
  • 52 Week Low
  • AIMD $0.40
  • JAGX $4.02
  • 52 Week High
  • AIMD $1.46
  • JAGX $502.50
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 50.95
  • JAGX 34.62
  • Support Level
  • AIMD $0.51
  • JAGX $10.41
  • Resistance Level
  • AIMD $0.57
  • JAGX $13.20
  • Average True Range (ATR)
  • AIMD 0.04
  • JAGX 1.53
  • MACD
  • AIMD -0.00
  • JAGX -0.55
  • Stochastic Oscillator
  • AIMD 36.71
  • JAGX 2.39

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: